However, more studies are needed to elucidate the intrinsic molecular mechanisms of SIRT1-mediated OLG survival and to better understand the role of SIRT1 in the remyelination of surviving OLGs in chronic MS lesions. This evidence concerns the gene SIRT1 and myeloid sarcoma.